The α7-nicotinic receptor is upregulated in immune cells from HIV-seropositive women: consequences to the cholinergic anti-inflammatory response

Clinical and Translational Immunology

Volumn 4, Issue 12, 2015, Pages

  Delgado Vélez, Manuel ^a   Báez Pagán, Carlos A ^a   Gerena, Yamil ^b   Quesada, Orestes ^a   Santiago Pérez, Laura I ^a   Capó Vélez, Coral M ^a   Wojna, Valerie ^a   Meléndez, Loyda ^a   León Rivera, Rosiris ^a   Silva, Walter ^a   Lasalde Dominicci, José A ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUNGAROTOXIN RECEPTOR; CHEMOKINE; CYTOKINE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 120 IIIB; GROWTH RELATED ONCOGENE ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; UNCLASSIFIED DRUG;

ARTICLE; CHOLINERGIC SYSTEM; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; MACROPHAGE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

EID: 85021670631     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/cti.2015.31     Document Type: Article

References (63)

1. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013; 39: 633–645.
2. Tien PC, Choi AI, Zolopa AR, Benson C, Tracy R, Scherzer R et al. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr 1999 2010; 55: 316–322.
3. McDonald B, Moyo S, Gabaitiri L, Gaseitsiwe S, Bussmann H, Koethe JR et al. Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. AIDS Res Hum Retroviruses 2013; 29: 993–999.
4. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62: 141–155.
5. Hearps AC, Martin GE, Rajasuriar R, Crowe SM. Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing. Curr HIV/AIDS Rep 2014; 11: 20–34.
6. Barré-Sinoussi F, Ross AL, Delfraissy J-F. Past, present and future: 30 years of HIV research. Nat Rev Microbiol 2013; 11: 877–883.
7. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214: 231–241.
8. Funderburg NT. Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients. Curr Opin HIV AIDS 2014; 9: 80–86.
9. + T cells, mediated via cell signaling and Tat cofactor overexpression. AIDS Lond Engl 2005; 19: 897–905.
10. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009; 9: 418–428.
11. Santos CC, dos dos, Shan Y, Akram A, Slutsky AS, Haitsma JJ. Neuroimmune regulation of ventilator-induced lung injury. Am J Respir Crit Care Med 2011; 183: 471–482.
12. Su X, Feng X, Terrando N, Yan Y, Chawla A, Koch LG et al. Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome. Mol Med Camb Mass 2012; 18: 1481–1490.
13. Norman GJ, Morris JS, Karelina K, Weil ZM, Zhang N, Al-Abed Y et al. Cardiopulmonary arrest and resuscitation disrupts cholinergic anti-inflammatory processes: a role for cholinergic α7 nicotinic receptors. J Neurosci Off J Soc Neurosci 2011; 31: 3446–3452.
14. Borges J, Soares P, Farinatti P. Autonomic modulation following exercise is impaired in HIV patients. Int J Sports Med 2012; 33: 320–324.
15. Robinson-Papp J, Sharma SK. Autonomic neuropathy in HIV is unrecognized and associated with medical morbidity. AIDS Patient Care STDs 2013; 27: 539–543.
16. Robinson-Papp J, Sharma S, Simpson DM, Morgello S. Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy. J Neurovirol 2013; 19: 172–180.
17. De Rosa MJ, Dionisio L, Agriello E, Bouzat C, Esandi MDC. Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci 2009; 85: 444–449.
18. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384–388.
19. Yoshikawa H, Kurokawa M, Ozaki N, Nara K, Atou K, Takada E et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 2006; 146: 116–123.
20. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005; 6: 844–851.
21. Báez-Pagán CA, Delgado-Vélez M, Lasalde-Dominicci JA. Activation of the macrophage α7 nicotinic acetylcholine receptor and control of inflammation. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 2015; 10: 468–476.
22. Bracci L, Lozzi L, Rustici M, Neri P. Binding of HIV-1 gp120 to the nicotinic receptor. FEBS Lett 1992; 311: 115–118.
23. González-Lira B, Rueda-Orozco PE, Galicia O, Montes-Rodríguez CJ, Guzmán K, Guevara-Martínez M et al. Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats. Neurosci Lett 2006; 394: 136–139.
24. Santosuosso M, Righi E, Lindstrom V, Leblanc PR, Poznansky MC. HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection. J Infect Dis 2009; 200: 1050–1053.
25. Popovic M, Tenner-Racz K, Pelser C, Stellbrink H-J, van Lunzen J, Lewis G et al. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci USA 2005; 102: 14807–14812.
26. Liu P, Overman RG, Yates NL, Alam SM, Vandergrift N, Chen Y et al. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. J Virol 2011; 85: 11196–11207.
27. Rangwala F, Drisdel RC, Rakhilin S, Ko E, Atluri P, Harkins AB et al. Neuronal alpha-bungarotoxin receptors differ structurally from other nicotinic acetylcholine receptors. J Neurosci Off J Soc Neurosci 1997; 17: 8201–8212.
28. Orr-Urtreger A, Göldner FM, Saeki M, Lorenzo I, Goldberg L, De Biasi M et al. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci Off J Soc Neurosci 1997; 17: 9165–9171.
29. Park-Wyllie LY, Antoniou T. Concurrent use of bupropion with CYP2B6 inhibitors, nelfinavir, ritonavir and efavirenz: a case series. AIDS Lond Engl 2003; 17: 638–640.
30. Currier MB, Molina G, Kato M. A prospective trial of sustained-release bupropion for depression in HIV-seropositive and AIDS patients. Psychosomatics 2003; 44: 120–125.
31. Pedrol-Clotet E, Deig-Comerma E, Ribell-Bachs M, Vidal-Castell I, García-Rodríguez P, Soler A. [Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy]. Enfermedades Infecc Microbiol Clínica 2006; 24: 509–511.
32. Chow D, Kocher M, Shikuma C, Parikh N, Grandinetti A, Nakamoto B et al. Effects of antiretroviral therapy on autonomic function in early HIV infection: a preliminary report. Int J Med Sci 2012; 9: 397–405.
33. Chow DC, Wood R, Choi J, Grandinetti A, Gerschenson M, Sriratanaviriyakul N et al. Cardiovagal autonomic function in HIV-infected patients with unsuppressed HIV viremia. HIV Clin Trials 2011; 12: 141–150.
34. Brownley KA, Milanovich JR, Motivala SJ, Schneiderman N, Fillion L, Graves JA et al. Autonomic and cardiovascular function in HIV spectrum disease: early indications of cardiac pathophysiology. Clin Auton Res Off J Clin Auton Res Soc 2001; 11: 319–326.
35. Ballester LY, Capó-Vélez CM, García-Beltrán WF, Ramos FM, Vázquez-Rosa E, Ríos R et al. Up-regulation of the neuronal nicotinic receptor α7 by HIV glycoprotein 120: potential implications for HIV-associated neurocognitive disorder. J Biol Chem 2012; 287: 3079–3086.
36. Gundavarapu S, Mishra NC, Singh SP, Langley RJ, Saeed AI, Feghali-Bostwick CA et al. HIV gp120 induces mucus formation in human bronchial epithelial cells through CXCR4/α7-nicotinic acetylcholine receptors. PLoS ONE 2013; 8: e77160.
37. Stitzel JA. Naturally occurring genetic variability in the nicotinic acetylcholine receptor alpha4 and alpha7 subunit genes and phenotypic diversity in humans and mice. Front Biosci J Virtual Libr 2008; 13: 477–491.
38. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953–964.
39. Raff HV, Picker LJ, Stobo JD. Macrophage heterogeneity in man. A subpopulation of HLA-DR-bearing macrophages required for antigen-induced T cell activation also contains stimulators for autologous-reactive T cells. J Exp Med 1980; 152: 581–593.
40. Witsell AL, Schook LB. Macrophage heterogeneity occurs through a developmental mechanism. Proc Natl Acad Sci USA 1991; 88: 1963–1967.
41. Giri MS, Nebozyhn M, Raymond A, Gekonge B, Hancock A, Creer S et al. Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance. J Immunol (Baltimore, Md: 1950) 2009; 182: 4459–4470.
42. Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 2007; 3: 1281–1290.
43. Mitchell AJ, Roediger B, Weninger W. Monocyte homeostasis and the plasticity of inflammatory monocytes. Cell Immunol 2014; 291: 22–31.
44. Gahring LC, Days EL, Kaasch T, González de Mendoza M, Owen L, Persiyanov K et al. Pro-inflammatory cytokines modify neuronal nicotinic acetylcholine receptor assembly. J Neuroimmunol 2005; 166: 88–101.
45. Kadiu I, Wang T, Schlautman JD, Dubrovsky L, Ciborowski P, Bukrinsky M et al. HIV-1 transforms the monocyte plasma membrane proteome. Cell Immunol 2009; 258: 44–58.
46. + blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81: 584–592.
47. Kinoshita S, Su L, Amano M, Timmerman LA, Kaneshima H, Nolan GP. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 1997; 6: 235–244.
48. 2+ in the replication and pathogenesis of rotavirus and other viral infections. Cell Calcium 2000; 28: 137–149.
49. Su X, Lee JW, Matthay ZA, Mednick G, Uchida T, Fang X et al. Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats. Am J Respir Cell Mol Biol 2007; 37: 186–192.
50. Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol (Baltimore, Md: 1950) 2009; 183: 6681–6688.
51. Chernyavsky AI, Arredondo J, Galitovskiy V, Qian J, Grando SA. Structure and function of the nicotinic arm of acetylcholine regulatory axis in human leukemic T cells. Int J Immunopathol Pharmacol 2009; 22: 461–472.
52. Altschuler EL, Kast RE. Bupropion in psoriasis and atopic dermatitis: decreased tumor necrosis factor-alpha? Psychosom Med 2003; 65: 719.
53. Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MBP. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 2006; 6: 903–907.
54. Del Cornò M, Donninelli G, Varano B, Da Sacco L, Masotti A, Gessani S. HIV-1 gp120 activates the STAT3/interleukin-6 axis in primary human monocyte-derived dendritic cells. J Virol 2014; 88: 11045–11055.
55. Gerena Y, Skolasky RL, Velez JM, Toro-Nieves D, Mayo R, Nath A et al. Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS ONE 2012; 7: e37358.
56. Wojna V, Carlson KA, Luo X, Mayo R, Meléndez LM, Kraiselburd E et al. Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: a case study. J Neurovirol 2004; 10 Suppl 1: 74–81.
57. Wojna V, Robles L, Skolasky RL, Mayo R, Selnes O, de la Torre T et al. Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women. J Neurovirol 2007; 13: 561–568.
58. Delgado-Vélez M, Lugo-Chinchilla A, Lizardo L, Morales I, Robles Y, Bruno N et al. Chronic exposure of human macrophages in vitro to morphine and methadone induces a putative tolerant/dependent state. J Neuroimmunol 2008; 196: 94–100.
59. Cheung R, Ravyn V, Wang L, Ptasznik A, Collman RG. Signaling mechanism of HIV-1 gp120 and virion-induced IL-1β release in primary human macrophages. J Immunol (Baltimore, Md: 1950) 2008; 180: 6675–6684.
60. Collman RG. HIV-1 Env-chemokine receptor interactions in primary human macrophages: entry and beyond. Res Initiat Treat Action 2003; 8: 6–9.
61. Roncarati R, Seredenina T, Jow B, Jow F, Papini S, Kramer A et al. Functional properties of alpha7 nicotinic acetylcholine receptors co-expressed with RIC-3 in a stable recombinant CHO-K1 cell line. Assay Drug Dev Technol 2008; 6: 181–193.
62. + regulatory T cells in mice in vitro. J Pharmacol Exp Ther 2010; 335: 553–561.
63. Borghi P, Fantuzzi L, Varano B, Gessani S, Puddu P, Conti L et al. Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J Virol 1995; 69: 1284–1287.